This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Artios Pharma Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Hollie McCarron
Introduction
Hollie McCarron is a notable inventor based in Cambridge, GB. She has made significant strides in the field of cancer treatment through her innovative research and development of heterocyclic compounds. Her work is not only groundbreaking but also essential in the ongoing fight against cancer.
Latest Patents
Hollie McCarron holds 1 patent for her invention titled "Heterocyclic compounds for use in the treatment of cancer." This patent relates to heterocyclic amide derivatives and their application in the treatment and prophylaxis of cancer. It also encompasses compositions containing these derivatives and the processes for their preparation.
Career Highlights
Hollie is currently employed at Artios Pharma Limited, where she continues to contribute to the advancement of cancer therapies. Her role at the company allows her to collaborate with other experts in the field, enhancing the impact of her work.
Collaborations
Hollie has worked alongside notable colleagues such as Peter Blencowe and Mark Charles. Their combined expertise fosters a collaborative environment that drives innovation in cancer treatment.
Conclusion
Hollie McCarron's contributions to cancer research through her patented inventions highlight her dedication to improving patient outcomes. Her work at Artios Pharma Limited exemplifies the importance of innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile